Blood Collection Tubes Market by Type (Plasma Separation Tube, Heparin Tubes, Serum Separating Tubes, EDTA Tubes, Rapid Serum Tubes, Others) by End-user (Diagnostic Centers, Healthcare Centers, Research and Development Centers, Blood Banks) - Growth, Future Prospects And Competitive Analysis, 2016 - 2028

About this report

The global blood collection tubes market report explores the critical analysis of the blood collection tube industry using key parameters. The report also provides a comprehensive analysis of key investment propositions, the demand and supply gap, competitor positioning, STAR analysis, SRC analysis, and Tornado analysis. Importantly, this report sets out major changes in the global technical regulations for the blood collection tube industry and how economic and non-economic barriers are helping the market grow. The report consists of investment strategies, the need for investments in the blood collection tubes industry, and the multiple benefits for investors. Moreover, the report analyzes the global, regional, and country-level historic and forecasted market sizes. Key technological developments and other analyses include Porter's five forces analysis, PESTEL analysis, value chain analysis, etc.


Blood Collection Tubes Market by Volume


Market by Value


Market, Tornado Analysis


Market, STAR Analysis


Market, SRC Analysis


Market, Import-Export Data

Yes (On Demand)

Market Pricing Analysis

Yes (On Demand)

Market Segment Analysis

By Product Type (Serum Separating Tube, Plasma Separation Tube, Rapid Serum Tubes, Heparin Tubes, EDTA Tubes, and Others)

By Material Type (Glass and Plastics)

By End-User (Diagnostic Centers, Healthcare Centers, and Research & Development Centers)

Market, Regional Analysis

North America (the US and Canada)

Europe (Germany, UK, France, Italy, Spain, and the Rest of Europe)

Asia Pacific (China, India, Japan, South Korea, South East Asia, and the Rest of Asia Pacific)

Latin America (Brazil, Mexico, and the Rest of Latin America)

Middle East and Africa (GCC Countries, South Africa, and the Rest of Middle East and Africa)

Market Key Companies

BD (US), Haematonics (US), Terumo BCT (US), Fresenius Kabi AG (Germany), Grifols S.A. (Spain), Nipro Medical Corporation (Japan), Greiner Holding (Austria), Quest Diagnostics (US), SARSTEDT AG & Co. KG (Germany), Macopharma (France), Smiths Medical (US), Cardinal Health (US), Retractable Technologies (US), and Liuyang Sanli Medical Technology Development (China)

Market Competitive Landscape

Market Share Analysis

Competitive Benchmarking

Key Players Market Positioning

Geographical Presence Analysis

Major Strategies Adopted


Key Highlights of the Report

How are the major segments performing in the blood collection tubes market?

  • The EDTA tubes segment led the market in terms of product type in 2021 and is presumed to continue with the largest share during the projection period owing to the increasing demand for serum testing in hematology. Serum tubes are appropriate for numerous blood tests as they are anticoagulants. Most hematology procedures use these tubes, including ablation therapy and blood transfusions. Its primary function is to perform a complete blood count.
  • The plastic material type segment held the largest global market share in 2021, owing to rising demand for plastic tubes and the low risk of tube breakage and specimen spillage, which prevented the sample from being exposed to bloodborne pathogens. The longer shelf life of plastics is expected to make them the most popular material for blood collection tubes for liquid biopsies.
  • In 2021, the diagnostic center segment of the end-user market dominated the global blood collection tube market. The factors can be attributed to primary centers for disease treatment and diagnosis. The growing number of diagnostic and screening tests drives demand for diagnostic and pathology laboratories. The increasing use of vacutainer tubes in diagnostic centers, owing to their security, ease of use, and lower risk of hemolysis, is fueling the growth of this segment.

Which region dominated the blood collection tube market?

North America dominated the global blood collection tube market in 2021 and is expected to maintain its dominance over the forecast period. The presence of top clinical diagnostics companies in North America has fueled the regional market and increased R&D activities due to the region's well-developed healthcare infrastructure. For instance, Q-Sera Pty Ltd. announced in August 2019 that the USPTO had granted the company a Notice of Allowance for the patent of blood clotting technology that will be used in blood collection tubes. Regional growth is also accelerated by cutting-edge technology and a focus on clinical research.

How is the US market performing in the blood collection tubes market?

The United States dominated the North American blood collection tube market in 2021 due to the country's significant manufacturers, improved healthcare infrastructure, rising incidence of blood disorders, and growing incidence of lifestyle diseases. Additionally, the American National Red Cross 2021 updates state that 36,000 RBC units are required. Approximately 21 million blood collection components are transfused annually in the United States. The country's blood transfusion rate is very high on the scale, assisting the growth of the North American blood-collection tube market. The rising senior population in the nation and the prevalence of several chronic diseases will further support market growth.

What is the competitive environment of the blood collection tube market?

The market for blood collection tubes is moderately competitive, with several major players. Major players use new product launches and R&D to grow their businesses and strengthen their positions in the global market. For instance, Abacus dx introduced RNA Complete BCT, the latest addition to Streck's trusted blood collection tube portfolio, in February 2022. Likewise, Q-Sera Pty Ltd signed an exclusive agreement with Terumo Corporation in November 2021 to produce and market Q-RAPClot Sera's rapid serum blood collection tube technology in Japan.

Executive Summary

What technical developments are being developed in the global blood collection tube market?

The industry is expected to grow faster as safe blood-collection technologies become more common. Technological advancements have increased the variety of blood collection tubes available for various applications, such as liquid biopsy. The constant development of novel diagnostic methods and products to improve patient safety is a key factor fueling the market's expansion. The need for secure tools, dependable procedures, and sterile blood collection methods has steadily risen. In addition, technological developments in the blood collection industry promote market expansion. An increase in regulatory approvals for technologically advanced products is expected to drive market growth over the forecast period. For instance, in March 2022, the American Food and Drug Administration (FDA) approved the ground-breaking plasma collection tube system developed by the medical technology company Terumo Blood and Cell Technologies. Similarly, Seventh Sense Biosystems announced in February 2018 that TAP, a push-button blood collection tube technique used to measure HbA1c levels in patients with prediabetes and diabetes, had received FDA 510(k) clearance.

Which are the key investments by the players in the blood collection tube market?

Blood collection tubes for a liquid biopsy that can be incorporated into applications like PCR, NGS, and DNA methylation assays will be commercialized due to ongoing product development investments. Leading market players concentrate on expanding their product portfolios and global reach and luring investments through acquisitions, mergers, and strategic partnerships. For example, Biodesix Inc. and Streck Inc. announced a Regulatory Cooperation Agreement in January 2020 to help businesses pursue FDA approval for diagnostic testing services and specimen collection tube products. Similarly, Qiagen and DiaSorin partnered in November 2019 to launch QuantiFERON-TB Plus (QFT-plus) to detect latent tuberculosis. The partnership made it possible to combine the LIAISON QuantiFERON-TB Plus detection assay from DiaSorin with the QuantiFERON-TB Gold-Plus Blood Collection Tube from Qiagen.

Some major players in the blood collection tubes market are BD (US), Haematonics (US), Terumo BCT (US), Fresenius Kabi AG (Germany), Grifols S.A. (Spain), Nipro Medical Corporation (Japan), Greiner Holding (Austria), Quest Diagnostics (US), SARSTEDT AG & Co. KG (Germany), Macopharma (France), Smiths Medical (US), Cardinal Health (US), Retractable Technologies (US), and Liuyang Sanli Medical Technology Development (China), and

What are the major driving factors for the blood collection tubes market?

The main driver of the blood collection tube market is the rising demand for accuracy and precision in analytical testing. The acceptance of advanced blood collection tubes has been influenced by the growing demand for improved blood sampling methods, the increasing demand for secure blood collection tools, and a preference for disposable laboratory products. The growing number of accidents, trauma cases, and surgeries worldwide also affects the blood collection tube market. The demand for more disposable laboratory supplies, safer blood collection technologies, and improved blood sampling techniques fuels market growth. The rising cost of healthcare contributes to developing the market's infrastructure and is a significant additional factor influencing its growth rate. Moreover, several government agencies are working to improve the healthcare system by providing more funding, which will impact the market's dynamics.

What are the major risks for the market for blood collection tubes?

Strict government regulations, a scarcity of experienced workers, the high cost of blood handling equipment, and the risk of blood transfusion are all expected to limit market growth. The scarcity of skilled professionals needed to operate instruments is a major impediment to the growth of the global market. Blood collection is a delicate technique, and incompetence or a lack of skill can derail the process. Such techniques necessitate the use of highly qualified and trained professionals who are conversant with the technology and mechanisms. Another restriction is the early expiration dates of glass and plastic blood collection tubes, typically restricted by the shelf life of additives as the water and vacuum vapor losses are minimal over time.


Which is the key product type in the blood collection tube market?

The EDTA tube segment is presumed to maintain its dominant position over the forecast period due to the increasing use of EDTA tubes in nearly all hematology processes, such as ablation therapy and blood transfusions. Ethylenediaminetetraacetic acid, or EDTA, is an anticoagulant used in almost all hematology procedures, such as blood typing and counting and identifying blood cells. EDTA tubes may contain K2 EDTA or K3 EDTA. EDTA has traditionally been recommended as the anticoagulant for hematological testing because it allows for the best preservation of cellular constituents and blood cell morphology. The potential uses for this anticoagulant, which can be used to balance blood for various conventional and innovative tests, have expanded due to the exceptional growth in laboratory test volume and complexity over the past few years. The number of accidents, blood transfusions during operations, and cancer treatments has increased, fueling the EDTA tube market's expansion.

How is the blood collection tube market performing in different regions?

North America will retain the largest blood collection tube market throughout the forecast period. Effective government research funding initiatives, a well-established healthcare industry, and technological advancements in the collection process are the main drivers of the regional blood collection tube market. Favorable healthcare policies and an increasing number of patients in the United States necessitating the use of EDTA tubes for blood collection are also propelling regional market growth. The prevalence of chronic illnesses like diabetes, thyroid disease, and other conditions requiring blood tests is also expected to increase, which will benefit the market. For example, the National Diabetes Statistics Report 2020 estimates that approximately 34.2 million Americans, or 10.5% of the population, have diabetes. About 1.6 million people in the USA have type 1 diabetes, comprising about 5.2% of all diagnosed cases. The rise in diabetes cases is projected to drive demand for blood collection tubes.

Furthermore, the Asia Pacific region is estimated to witness the fastest growth in the global blood collection tube market over the coming years due to an increase in the occurrence of infectious diseases, an aging population, an increase in product approvals and launches, an increase in demand for diagnostic techniques, and the high prevalence of bloodstream infections. The region's dense population and the rising demand for routine check-ups owing to the prevalence of diseases like diabetes, cancer, liver diseases, and cardiovascular disorders will also contribute to the market's revenue growth. Government initiatives in the region to increase drug awareness, blood drives, and the personalization of medications based on body type are some of the benefits for the market.

What is the regulatory landscape for the blood collection tube market?

Blood collection tubes are critical diagnostic products for laboratory testing such as biopsy. Blood collection tubes for liquid biopsies provide the diagnostic process with speed, precision, accuracy, safety, and ease of use. Government initiatives to improve regulatory measures and investments in R&D and healthcare are expected to drive demand due to the advent of better and non-invasive techniques used to detect tumor-specific aberrations, resulting in market growth in the upcoming years. Blood collection tubes for liquid biopsy will be used more frequently globally due to rising technological developments, mergers and acquisitions, product launches, and strategic alliances formed by top industry players. They will continue introducing new blood collection tube product developments to the international market. Moreover, regulatory bodies are constantly attempting to create favorable scenarios for developing and commercializing blood collection tubes for liquid biopsy to produce high-quality diagnostic assay methodologies for cancers and other chronic diseases.

What is the market size of blood collection tubes in terms of value?

The global blood collection tube market is anticipated to grow at a substantial CAGR of 7.3% in the upcoming years. The global blood collection tube industry is estimated to be worth USD 1248.5 million in 2021 and is expected to be worth USD 1905.4 million by 2028.

What are the major players planning for the future of the blood collection tube market?

The blood collection tube market is highly fragmented, with many large, medium, and small players accounting for the majority of market revenue.Major players are implementing various strategies, including mergers and acquisitions, strategic alliances and contracts, and developing, testing, and introducing more effective blood collection products. One of the major players, Abbott Laboratories, reported that its testing platforms conduct about 4 billion tests annually. BD is also the world's largest manufacturer of blood tubes and the creator of the BD vacutainer blood collection tubes. Important players also use organic growth strategies, like partnerships with governments, to expand the geographic reach of their product portfolio. For instance, in April 2022, America's Blood Centers, Blood Centers of America, and Fresenius Kabi announced their partnership to help those affected in Ukraine across the nation by providing essential blood collection tubes and transfusion supplies.

Segmentation of Global Blood Collection Tubes Market -

Global Blood Collection Tubes Market – By Product Type

  • Serum Separating Tube
  • Plasma Separation Tube
  • Rapid Serum Tubes
  • Heparin Tubes
  • EDTA Tubes
  • Others

Global Blood Collection Tubes Market – By Material Type

  • Glass
  • Plastics

Global Blood Collection Tubes Market – By End-User

  • Diagnostic Centers
  • Healthcare Centers
  • Research & Development Centers

Global Blood Collection Tubes Market – By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • South-east Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of the Middle East and Africa

Frequently asked questions about the global market for blood collection tubes

Likewise other industries, COVID 19 also taken a toll on Blood Collection Tubes market with around 5% decline in its revenue in 2020 as compare to that of projected USD 1,312 million

North America is the largest regional market with highest share in the total volume of Blood Collection Tubes consumed in 2021

Strong growth of diagnostic industry and increasing demand for serum sample to fuel the growth of this industry

Serum Separating Tubes segment dominated the Blood Collection Tubes market in 2021 with over 35% share

Diagnostic Centers was the largest End-user of Blood Collection Tubes in 2021 with over 40% share

Blood Collection Tubes Report Scope

Report Attribute Details
Market Value in 2021 USD 1248.5 million
Market Value in 2028 USD 1905.4 million
CAGR 7.3%
Benchmarking Year 2021
Past data 2016 – 2021
Forecast period 2022 – 2028
Choose License Type
Trusted By
Published Date:  Dec 2022
Category:  Medical Devices
Report ID:   60516
Report Format:   PDF
Pages:   128
Rating:    4.6 (16)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
24/7 Research Support